1-乙氧基-4-(4-甲氧基苯基)苯 | 644964-54-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-乙氧基-4-(4-甲氧基苯基)苯
• 英文名称: 4-ethoxy-4'-methoxy-1,1'-biphenyl
• 英文别名: 1-ethoxy-4-(4-methoxyphenyl)benzene
• CAS: 644964-54-5
• 化学式: C₁₅H₁₆O₂
• 分子量: 228.291
• InChiKey: YWCJWMWIEHZSOZ-UHFFFAOYSA-N

物化性质

• 熔点：
  152 °C
• 沸点：
  352.6±35.0 °C(Predicted)
• 密度：
  1.041±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  四氯化碳 、 氯仿 、 1-乙氧基-4-(4-甲氧基苯基)苯 、 硝酸 生成 alkaline earth salt of/the/ methylsulfuric acid
  参考文献：
  名称：

  Tax-Aided Financial Services Companies and the Cost of Capital

  摘要：

  AbstractOver the past two decades, the governments of several European countries have implemented special tax devices to attract the finance centres of multinational companies. This paper determines how the cost of capital for investments made by multinationals is affected by the tax regimes, bringing into play the Irish financial services company, the Belgian co‐ordination centre, the Dutch finance company and the Luxemburg company coupled with a Swiss finance branch. It gives evidence that intermediation of a tax‐aided services company in the financing scheme of a foreign subsidiary provides an important tax saving. However, the home and source countries' tax regimes influence the hierarchy of the less heavily taxed treasury and finance centres. The methodology relies on the marginal effective tax rates theory and consists of an extension of Alworth's (1988) model to include treasury centres.

  DOI：

  10.1111/j.1475-5890.2000.tb00028.x
• 作为产物：
  描述：

  4,4'-二羟基联苯 在 sodium hydroxide 、 乙醇 作用下， 生成 1-乙氧基-4-(4-甲氧基苯基)苯
  参考文献：
  名称：

  Tax-Aided Financial Services Companies and the Cost of Capital

  摘要：

  AbstractOver the past two decades, the governments of several European countries have implemented special tax devices to attract the finance centres of multinational companies. This paper determines how the cost of capital for investments made by multinationals is affected by the tax regimes, bringing into play the Irish financial services company, the Belgian co‐ordination centre, the Dutch finance company and the Luxemburg company coupled with a Swiss finance branch. It gives evidence that intermediation of a tax‐aided services company in the financing scheme of a foreign subsidiary provides an important tax saving. However, the home and source countries' tax regimes influence the hierarchy of the less heavily taxed treasury and finance centres. The methodology relies on the marginal effective tax rates theory and consists of an extension of Alworth's (1988) model to include treasury centres.

  DOI：

  10.1111/j.1475-5890.2000.tb00028.x

文献信息

• Substituted benzazoles and methods of their use as inhibitors of Raf kinase
  申请人：——

  公开号：US20040122237A1

  公开（公告）日：2004-06-24

  New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.

  提供了新的替代苯唑化合物、组合物和抑制人类或动物主体中Raf激酶活性的方法。这些新化合物组合物可以单独使用，也可以与至少一种额外药物结合，用于治疗由Raf激酶介导的疾病，如癌症。
• [EN] COMPOUNDS USEFUL FOR TREATING A MANNHEIMIA HAEMOLYTICA OR HISTOPHILUS SOMNI INFECTION<br/>[FR] COMPOSÉS UTILES POUR TRAITER UNE INFECTION PAR MANNHEIMIA HAEMOLYTICA OU HISTOPHILUS SOMNI
  申请人：INTERVET INT BV

  公开号：WO2018115421A1

  公开（公告）日：2018-06-28

  The present invention discloses compounds of formula (I) that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).

  本发明公开了一种化合物，其化学式为（I），可用于治疗动物的呼吸道疾病，特别是牛或猪的呼吸道疾病（BRD和SRD）。
• Nickel‐ and Palladium‐Catalyzed Cross‐Coupling Reactions of Organostibines with Organoboronic Acids
  作者：Dejiang Zhang、Liyuan Le、Renhua Qiu、Wai‐Yeung Wong、Nobuaki Kambe

  DOI：10.1002/anie.202011491

  日期：2021.2.8

  successful synthesis of arylated stibine 3 a in a scale of 34.77 g demonstrates high synthetic potential of this transformation. The formed stibines (R3Sb) were then used for the palladium‐catalyzed carbon–carbon bond forming reaction with aryl boronic acids [R−B(OH)2], giving biaryls with high selectivity, even the structures of two organomoieties (R and R′) are very similar. Plausible catalytic pathways

  镍催化的halostibines交叉偶联，开发了一种形成锑-碳键的策略。该方法已被用于从相应的环状和非环状halostibines合成各种三芳基和二芳基烷基stibines。该方案显示了广泛的底物范围（72个实例），并且与各种官能团（如醛，酮，烯烃，炔烃，卤代芳烃（F，Cl，Br，I）和杂芳烃）兼容。成功合成规模为34.77 g的芳基锑化3a证明了这种转化的高合成潜力。然后将形成的stibines（R 3 Sb）用于与芳基硼酸[ RB （OH）2的钯催化的碳-碳键形成反应，从而产生具有高选择性的联芳基，甚至两个有机基团（R和R'）的结构也非常相似。根据控制实验提出了合理的催化途径。
• Suzuki–Miyaura cross-coupling reaction assisted by palladium nanoparticles-decorated zeolite 13X nanocomposite: a greener approach
  作者：Raja Deepika、Mathur Gopalakrishnan Sethuraman

  DOI：10.1007/s11164-021-04651-z

  日期：2022.3

  Heterogeneous catalysts govern the field of catalysis due to their easy separation from a reaction mixture, reusability, and prevention of agglomeration, making them more efficient catalysts than homogeneous catalysts. Herein, we report the eco-friendly synthesis of a novel heterogeneous catalyst, viz. palladium nanoparticles (Pd NPs) decorated over zeolite 13X nanocomposite using dried fruits of Terminalia

  非均相催化剂因其易于从反应混合物中分离、可重复使用和防止团聚而支配着催化领域，使其成为比均相催化剂更有效的催化剂。在此，我们报告了一种新型多相催化剂的环保合成，即。钯纳米粒子 (Pd NPS) 使用Terminalia chebula干果装饰在沸石 13X 纳米复合材料上雷兹。作为还原剂和稳定剂及其作为铃木-宫浦偶联反应的有希望的催化剂的性能。使用傅里叶变换红外光谱（FTIR）、X射线衍射（XRD）、场发射扫描电子显微镜（FESEM）、高分辨率透射电子显微镜（ HR-TEM)、热重分析 (TGA)、X 射线光电子能谱 (XPS) 和 Brunauer-Emmett-Teller (BET) 分析证实了 13X 沸石表面上存在钯纳米颗粒。FESEM 图像显示在沸石 13X 的立方颗粒上存在球形 Pd NP。发现钯纳米粒子的平均粒径在 6-7 nm 范围内，本质上是多晶的。从 BET 分析推断，Pd
• 2,6-Disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of RAF kinase
  申请人：Ramurthy Savithri

  公开号：US20050085482A1

  公开（公告）日：2005-04-21

  New substituted quinazoline, quinoxaline, quinoline and isoquinoline compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.

  提供了新的替代喹唑啉、喹喔啉、喹啉和异喹啉化合物、组合物以及在人类或动物主体中抑制Raf激酶活性的方法。这些新化合物组合物可以单独使用，也可以与至少一种额外药物联合使用，用于治疗由Raf激酶介导的疾病，如癌症。